ANI Pharmaceuticals CEO Arthur Przybyl To Depart On May 10 - Quick Facts

ANI Pharmaceuticals, Inc. (ANIP) announced Tuesday that Arthur Przybyl will depart as President and Chief Executive Officer on May 10, 2020 after serving in the roles for 11 years.

The Board and Przybyl have determined that the time is right to transition to new leadership as the Company prepares to launch Cortrophin Gel and expand its portfolio of specialty pharmaceutical products.

The Board of Directors has retained a nationally recognized executive search firm to lead the search for a new President and Chief Executive Officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning. Science and technology firm Danaher Corp. (DHR) announced Thursday that it has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or proceeds from the issuance... Biopharmaceutical company Kite Pharma, a part of Gilead Sciences, Inc. (GILD), and biotechnology company Shoreline Biosciences, Inc. announced Thursday a strategic partnership to develop novel cell therapies across a variety of cancer targets. The partnership follows Kite's investment in Shoreline's...
Follow RTT